ChemicalBook >> CAS DataBase List >>Hu1D10

Hu1D10

CAS No.
267227-08-7
Chemical Name:
Hu1D10
Synonyms
Apolizumab;Hu1D10;Research Grade Apolizumab;Research Grade Apolizumab (DHB96801)
CBNumber:
CB02494652
Molecular Formula:
Molecular Weight:
0
MDL Number:
MOL File:
Mol file
TDS File:
TDS
Last updated:2026-04-24 14:58:24

Hu1D10 Properties

NCI Dictionary of Cancer Terms apolizumab
FDA UNII G88KCP51RE
NCI Drug Dictionary apolizumab

Hu1D10 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth CLA1060 Apolizumab 267227-08-7 1mg $2310 2026-06-04 Buy
Biosynth CLA1060 Apolizumab 267227-08-7 5mg $4042.5 2026-06-04 Buy
Biosynth CLA1060 Apolizumab 267227-08-7 10mg $7218.8 2026-06-04 Buy
Product number Packaging Price Buy
CLA1060 1mg $2310 Buy
CLA1060 5mg $4042.5 Buy
CLA1060 10mg $7218.8 Buy

Hu1D10 Chemical Properties, Uses, Production

Uses

Anti-cancer agent against 1D10 antigen positive B-cell malignancies.

Hu1D10 Preparation Products And Raw materials

Raw materials

Preparation Products

Hu1D10 Suppliers

Global Suppliers ( 13)
Supplier Tel Email Country ProdList Advantage
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
BOC Sciences 16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
Wuhan Chemstan Biotechnology Co., Ltd. 027-65317797 15926423062 422450190@qq.com China 10300 58
Biolab Reagents 027-65279366 18108604356 products@biolabreagent.com China 9864 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 086-15871494362 13720134139 orders@jknbiochem.com China 7414 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Changsha Fuzhen Biotechnology Co.,LTD 15111215862 18229892877 3062105966@qq.com China 5584 58
Olix ( Hubei) Pharmaceutical Technology Co., Ltd 17316404525 17316404525 209533805@qq.com China 9790 58
Atagenix Laboratories 027-87008169 17762441161 info@atagenix.com China 9997 58
Hu1D10 Research Grade Apolizumab (DHB96801) Research Grade Apolizumab Apolizumab 267227-08-7